DarioHealth Corp.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $22.4M | $27.0M | $20.4M | $27.7M | $20.5M |
| Gross profit | $12.7M | $13.3M | $6.0M | $9.7M | $4.0M |
| Operating income | -$36.7M | -$57.7M | -$56.2M | -$56.8M | -$76.5M |
| Operating expenses | $49.3M | $71.0M | $62.2M | $66.5M | $80.5M |
| Cost of revenue | $9.7M | $13.8M | $14.4M | $18.0M | $16.6M |
| Cash from operations | -$25.9M | -$38.6M | -$30.4M | -$47.8M | -$50.4M |
| Capital expenditure | $142,000 | $138,000 | $584,000 | $442,000 | $261,000 |
| Free cash flow | -$26.1M | -$38.7M | -$31.0M | -$48.3M | -$50.7M |
| Share repurchases | — | — | — | $134,000 | — |
| Impairments | $0 | $860,000 | $0 | $0 | $0 |
| Total assets | $110.1M | $118.9M | $96.4M | $119.2M | $100.8M |
Shares outstanding 7.3M · Free float 60.0%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.